Literature DB >> 31712223

The Elimination of Hepatitis C as a Public Health Threat.

Margaret Hellard1,2,3,4, Sophia E Schroeder1,2, Alisa Pedrana1,2, Joseph Doyle1,3, Campbell Aitken1,2.   

Abstract

Hepatitis C virus is a global public health threat, affecting 71 million people worldwide. Increasing recognition of the impact of this epidemic and recent advances in biomedical and technical approaches to hepatitis C prevention and cure have provided impetus for the World Health Organization (WHO) to call for global elimination of hepatitis C as a public health threat by 2030. This work reviews the feasibility of hepatitis C elimination and pathways to overcome existing and potential future barriers to elimination. Drawing on cost-effectiveness modeling and providing examples of successful implementation efforts across the globe, we highlight the resources and strategies needed to achieve hepatitis C elimination. A timely, multipronged response is required if the 2030 WHO elimination targets are to be achieved. Importantly, achieving hepatitis C elimination will also benefit the community well beyond 2030.
Copyright © 2020 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31712223      PMCID: PMC7117951          DOI: 10.1101/cshperspect.a036939

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  90 in total

1.  Minimization of hepatitis B infection by a 25-year universal vaccination program.

Authors:  Yen-Hsuan Ni; Mei-Hwei Chang; Jia-Feng Wu; Hong-Yuan Hsu; Huey-Ling Chen; Ding-Shinn Chen
Journal:  J Hepatol       Date:  2012-06-02       Impact factor: 25.083

2.  Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia.

Authors:  Joseph S Doyle; Nick Scott; Rachel Sacks-Davis; Alisa E Pedrana; Alexander J Thompson; Margaret E Hellard
Journal:  Aliment Pharmacol Ther       Date:  2019-03-25       Impact factor: 8.171

3.  Effects of Treatment of Chronic Hepatitis B Virus Infection on Patient-Reported Outcomes.

Authors:  Zobair M Younossi; Maria Stepanova; Harry L A Janssen; Kosh Agarwal; Mindie H Nguyen; Ed Gane; Naoky Tsai; Issah Younossi; Andrei Racila
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-02       Impact factor: 11.382

4.  Sexual transmission of hepatitis C virus among gay and bisexual men: a systematic review.

Authors:  Fengyi Jin; Gail V Matthews; Andrew E Grulich
Journal:  Sex Health       Date:  2017-02       Impact factor: 2.706

5.  Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-03-15

6.  Cost-Effectiveness Analysis of New HCV Treatments in Egyptian Cirrhotic and Non-Cirrhotic Patients: A Societal Perspective.

Authors:  Gihan Hamdy Elsisi; Asmaa Aburawash; Emam Waked
Journal:  Value Health Reg Issues       Date:  2017-07-26

7.  The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.

Authors:  Jeffrey D Stanaway; Abraham D Flaxman; Mohsen Naghavi; Christina Fitzmaurice; Theo Vos; Ibrahim Abubakar; Laith J Abu-Raddad; Reza Assadi; Neeraj Bhala; Benjamin Cowie; Mohammad H Forouzanfour; Justina Groeger; Khayriyyah Mohd Hanafiah; Kathryn H Jacobsen; Spencer L James; Jennifer MacLachlan; Reza Malekzadeh; Natasha K Martin; Ali A Mokdad; Ali H Mokdad; Christopher J L Murray; Dietrich Plass; Saleem Rana; David B Rein; Jan Hendrik Richardus; Juan Sanabria; Mete Saylan; Saeid Shahraz; Samuel So; Vasiliy V Vlassov; Elisabete Weiderpass; Steven T Wiersma; Mustafa Younis; Chuanhua Yu; Maysaa El Sayed Zaki; Graham S Cooke
Journal:  Lancet       Date:  2016-07-07       Impact factor: 79.321

8.  Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17-18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework.

Authors:  Stephanie Popping; Manal El-Sayed; Jordan Feld; Angelos Hatzakis; Margaret Hellard; Olufunmilayo Lesi; Michael Ninburg; John Ward; Charles Boucher
Journal:  J Virus Erad       Date:  2018-07-01

Review 9.  Interventions to optimise the care continuum for chronic viral hepatitis: a systematic review and meta-analyses.

Authors:  Kali Zhou; Thomas Fitzpatrick; Nick Walsh; Ji Young Kim; Roger Chou; Mellanye Lackey; Julia Scott; Ying-Ru Lo; Joseph D Tucker
Journal:  Lancet Infect Dis       Date:  2016-09-05       Impact factor: 25.071

10.  Continuum of hepatitis C care in France: A 20-year cohort study.

Authors:  Coralie Hermetet; Frederic Dubois; Catherine Gaudy-Graffin; Yannick Bacq; Bernard Royer; Christophe Gaborit; Louis D'Alteroche; Jean Claude Desenclos; Philippe Roingeard; Leslie Grammatico-Guillon
Journal:  PLoS One       Date:  2017-08-29       Impact factor: 3.240

View more
  1 in total

Review 1.  Macrophage Polarization and Its Role in Liver Disease.

Authors:  Cheng Wang; Cheng Ma; Lihong Gong; Yuqin Guo; Ke Fu; Yafang Zhang; Honglin Zhou; Yunxia Li
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.